draft agenda for phone call with EPO
Dear all
as agreed, I drafted some agenda for the phone call on 14 July.
please see below.
I would send this draft (after corrections etc) to EPO tomorrow morning
please let me know your comments
thanks!
Christoph
Dear..
During the meeting with the EPO we would like to focus on for topics and then potentially discuss other issues. These four topics are (as outlinied in our letter):
* definition of essentially biological processes * patentability of cells * scope of patents * effect of G3/19 on pending patent applications
To discuss the issue, we propose the following agenda:
1. Short introduction of participants
2. Short summary of problems remaining or newly emerging after G3/19 from the perspective of No Patents on Seeds!
3. Some comments from the EPO on the problem analysis of No Patents on Seeds!
4. First round of discussion / questions
5. Short summary of possible solutions as proposed by No Patents on Seeds!
6. Some comments from the EPO on the solutions analysis of No Patents on Seeds!
7. Second round of discussion / questions
8. Short summary on the findings
9. Other issues such as transparency and CSO participation in meetings of the Administrative Council
10. Further exchanges of views between No Patents on Seeds and the EPO in near future
Many thanks Christoph,
Looking ok from my side. Just wondering whether you do not want to table the (non)patentability of random mutagenesis more explicitly in the agenda, e.g. under or as part of agenda point 1 - definition of EBP. Best regards, Bram
From: Npos_2018 npos_2018-bounces@testbiotech.de On Behalf Of Christoph Then Sent: Wednesday, 8 July 2020 10:04 To: npos_2018@testbiotech.de Subject: [Npos_2018] draft agenda for phone call with EPO
Dear all
as agreed, I drafted some agenda for the phone call on 14 July.
please see below.
I would send this draft (after corrections etc) to EPO tomorrow morning
please let me know your comments
thanks!
Christoph
Dear..
During the meeting with the EPO we would like to focus on for topics and then potentially discuss other issues. These four topics are (as outlinied in our letter):
* definition of essentially biological processes * patentability of cells * scope of patents * effect of G3/19 on pending patent applications
To discuss the issue, we propose the following agenda:
1. Short introduction of participants
2. Short summary of problems remaining or newly emerging after G3/19 from the perspective of No Patents on Seeds!
3. Some comments from the EPO on the problem analysis of No Patents on Seeds!
4. First round of discussion / questions
5. Short summary of possible solutions as proposed by No Patents on Seeds!
6. Some comments from the EPO on the solutions analysis of No Patents on Seeds!
7. Second round of discussion / questions
8. Short summary on the findings
9. Other issues such as transparency and CSO participation in meetings of the Administrative Council
10. Further exchanges of views between No Patents on Seeds and the EPO in near future
Thanks Christoph, fine for me
Get Outlook for Androidhttps://aka.ms/ghei36
________________________________ From: Npos_2018 npos_2018-bounces@testbiotech.de on behalf of Bram de Jonge Bram.de.Jonge@oxfamnovib.nl Sent: Wednesday, July 8, 2020 2:13:30 PM To: Christoph Then info@no-patents-on-seeds.org; npos_2018@testbiotech.de npos_2018@testbiotech.de Subject: Re: [Npos_2018] draft agenda for phone call with EPO
Many thanks Christoph,
Looking ok from my side. Just wondering whether you do not want to table the (non)patentability of random mutagenesis more explicitly in the agenda, e.g. under or as part of agenda point 1 - definition of EBP.
Best regards,
Bram
From: Npos_2018 npos_2018-bounces@testbiotech.de On Behalf Of Christoph Then Sent: Wednesday, 8 July 2020 10:04 To: npos_2018@testbiotech.de Subject: [Npos_2018] draft agenda for phone call with EPO
Dear all
as agreed, I drafted some agenda for the phone call on 14 July.
please see below.
I would send this draft (after corrections etc) to EPO tomorrow morning
please let me know your comments
thanks!
Christoph
Dear..
During the meeting with the EPO we would like to focus on for topics and then potentially discuss other issues. These four topics are (as outlinied in our letter):
* definition of essentially biological processes * patentability of cells * scope of patents * effect of G3/19 on pending patent applications
To discuss the issue, we propose the following agenda:
1. Short introduction of participants
2. Short summary of problems remaining or newly emerging after G3/19 from the perspective of No Patents on Seeds!
3. Some comments from the EPO on the problem analysis of No Patents on Seeds!
4. First round of discussion / questions
5. Short summary of possible solutions as proposed by No Patents on Seeds!
6. Some comments from the EPO on the solutions analysis of No Patents on Seeds!
7. Second round of discussion / questions
8. Short summary on the findings
9. Other issues such as transparency and CSO participation in meetings of the Administrative Council
10. Further exchanges of views between No Patents on Seeds and the EPO in near future
this would be point Nr 1.
Am 08.07.20 um 14:13 schrieb Bram de Jonge:
Many thanks Christoph,
Looking ok from my side. Just wondering whether you do not want to table the (non)patentability of random mutagenesis more explicitly in the agenda, e.g. under or as part of agenda point 1 - definition of EBP.
Best regards,
Bram
*From:*Npos_2018 npos_2018-bounces@testbiotech.de *On Behalf Of *Christoph Then *Sent:* Wednesday, 8 July 2020 10:04 *To:* npos_2018@testbiotech.de *Subject:* [Npos_2018] draft agenda for phone call with EPO
Dear all
as agreed, I drafted some agenda for the phone call on 14 July.
please see below.
I would send this draft (after corrections etc) to EPO tomorrow morning
please let me know your comments
thanks!
Christoph
Dear..
During the meeting with the EPO we would like to focus on for topics and then potentially discuss other issues. These four topics are (as outlinied in our letter):
- definition of essentially biological processes
- patentability of cells
- scope of patents
- effect of G3/19 on pending patent applications
To discuss the issue, we propose the following agenda:
Short introduction of participants
Short summary of problems remaining or newly emerging after G3/19
from the perspective of No Patents on Seeds!
- Some comments from the EPO on the problem analysis of No Patents on
Seeds!
First round of discussion / questions
Short summary of possible solutions as proposed by No Patents on
Seeds!
- Some comments from the EPO on the solutions analysis of No Patents
on Seeds!
Second round of discussion / questions
Short summary on the findings
Other issues such as transparency and CSO participation in meetings
of the Administrative Council
- Further exchanges of views between No Patents on Seeds and the EPO
in near future
Npos_2018 mailing list Npos_2018@testbiotech.de https://lists.testbiotech.de/cgi-bin/mailman/listinfo/npos_2018
participants (3)
-
ARCHE NOAH Katherine Dolan -
Bram de Jonge -
Christoph Then